Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
2
×
life sciences
national blog main
andrew berens
avapritinib
biotech
blueprint medicines
boehringer ingelheim
boston
boston blog main
cancer
deciphera pharmaceuticals
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
gastrointestinal stromal tumor
gist
gleevec
imatinib
indiana blog main
indiana top stories
new york blog main
new york top stories
regorafenib
ripretinib
slgt2 inhibitor
steve hoerter
stivarga
sunitinib
sutent
svb leerink
type 1 diabetes
type 2 diabetes
What
approval
2
×
drug
2
×
fda
type
2
×
announced
bid
blueprint
boehringer
cancer
chasing
deadly
deciphera
diabetes
eli
expand
fallen
filing
forms
gi
ingelheim
lilly
marketed
medicine
medicine’s
morning
patients
pharamceuticals
plans
rejects
seek
short
treats
tumor
Language
unset
Current search:
drug
×
approval
×
" clinical trials "
×
type
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug